---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-042169"
form_type: "8-K"
ticker: null
cik: "0001850051"
company_name: "Intelligent Medicine Acquisition Corp."
filed_at: "2023-04-05T23:59:59+00:00"
generated_at: "2026-06-17T06:03:08.562773+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nasdaq notifies Intelligent Medicine Acquisition Corp of delisting for unpaid fees and insufficient publicly held shares

## Summary
- Received Nasdaq letter on March 30, 2023 citing unpaid fees of $140,000 and failure to meet minimum 1,100,000 publicly held shares.
- Non-compliance stems from 20,009,861 shares redeemed at Feb 8, 2023 special meeting.
- Trading suspension set for April 11, 2023 unless appeal is filed; company intends to request hearing.
- Delisting would lead to Form 25-NSE filing with SEC.

## SEC filing metadata
- accession: 0001104659-23-042169
- form_type: 8-K
- cik: 0001850051
- company_name: Intelligent Medicine Acquisition Corp.
- filed_at: 2023-04-05T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850051/000110465923042169/0001104659-23-042169-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850051/000110465923042169/tm2311871-1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-042169
- JSON: https://secwatch.observer/filing/0001104659-23-042169.json
- Plain text: https://secwatch.observer/filing/0001104659-23-042169.txt

## Key facts
- Listing & Compliance Notices
  Intelligent Medicine Acquisition Corp. received a nasdaq noncompliance notice notice regarding other (rules 5450(b)(2)(B)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Rules: 5450(b)(2)(B)
  source text: March 30, 2023, Intelligent Medicine Acquisition Corp. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications division (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not paid certain fees required by Nasdaq Listing Rule 5250(f) and that the Company will be delisted unless it appeals such determination. As of the date of the Notice, the Company’s past due fee balance totaled $140,000. If the Company elects not to appeal, trading of its Class A ordinary shares will be suspended at the opening of business on April 11, 2023 and a Form
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850051/000110465923042169/0001104659-23-042169-index.htm
- Listing & Compliance Notices
  Intelligent Medicine Acquisition Corp. received a nasdaq deficiency notice notice regarding other (rules 5250(f), 5450(b)(2)(B), 5810(c)(2)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Rules: 5250(f), 5450(b)(2)(B), 5810(c)(2)(A)
  source text: March 30, 2023, Intelligent Medicine Acquisition Corp. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications division (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not paid certain fees required by Nasdaq Listing Rule 5250(f) and that the Company will be delisted unless it appeals such determination. As of the date of the Notice, the Company’s past due fee balance totaled $140,000. If the Company elects not to appeal, trading of its Class A ordinary shares will be suspended at the opening of business on April 11, 2023 and a Form
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850051/000110465923042169/0001104659-23-042169-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.